Multimodality imaging can shift the clinical approach and prognosis of a patient: from heart failure and angina to cardiac amyloidosis

1 Fine NM, Davis MK, Anderson K, et al. Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis. Canadian Journal of Cardiology. 2020;36(3):322–334. FineNM DavisMK AndersonK Canadian Cardiovascular Society/Canadian Heart Failure Society Joint Position Statement on the Evaluation and Management of Patients With Cardiac Amyloidosis Canadian Journal of Cardiology 2020 36 3 322 334 10.1016/j.cjca.2019.12.03432145862 Search in Google Scholar

2 Khanna S, Wen I, Bhat A, et al. The Role of Multimodality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update Frontiers in Cardiovascular Medicine. 2020;7:212. KhannaS WenI BhatA The Role of Multimodality Imaging in the Diagnosis of Cardiac Amyloidosis: A Focused Update Frontiers in Cardiovascular Medicine 2020 7 212 10.3389/fcvm.2020.590557766168933195479 Search in Google Scholar

3 Kittleson MM, Maurer MS, Ambardekar AV, et al. Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association. Circulation. 2020;142(1):7–22. KittlesonMM MaurerMS AmbardekarAV Cardiac Amyloidosis: Evolving Diagnosis and Management: A Scientific Statement From the American Heart Association Circulation 2020 142 1 7 22 10.1161/CIR.000000000000079232476490 Search in Google Scholar

4 Pun SC, Landau HJ, Riedel ER, et al. Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation. Journal of the American Society of Echocardiography. 2018;31(1):64–70. PunSC LandauHJ RiedelER Prognostic and Added Value of Two-Dimensional Global Longitudinal Strain for Prediction of Survival in Patients with Light Chain Amyloidosis Undergoing Autologous Hematopoietic Cell Transplantation Journal of the American Society of Echocardiography 2018 31 1 64 70 10.1016/j.echo.2017.08.017598566429111123 Search in Google Scholar

5 Nguyen HT, Nguyen CTH. Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review. European Heart Journal - Case Reports. October 2020. NguyenHT NguyenCTH Cardiac amyloidosis mimicking acute coronary syndrome: a case report and literature review European Heart Journal - Case Reports October 2020 10.1093/ehjcr/ytaa325779319333442652 Search in Google Scholar

6 Neben-Wittich MA, Wittich CM, Mueller PS, Larson DR, Gertz MA, Edwards WD. Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis. The American Journal of Medicine. 2005;118(11):1287. Neben-WittichMA WittichCM MuellerPS LarsonDR GertzMA EdwardsWD Obstructive intramural coronary amyloidosis and myocardial ischemia are common in primary amyloidosis The American Journal of Medicine 2005 118 11 1287 10.1016/j.amjmed.2005.06.01716271914 Search in Google Scholar

7 Dorbala S, Vangala D, Bruyere J, et al. Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis. JACC: Heart Failure. 2014;2(4):358–367. DorbalaS VangalaD BruyereJ Coronary Microvascular Dysfunction Is Related to Abnormalities in Myocardial Structure and Function in Cardiac Amyloidosis JACC: Heart Failure 2014 2 4 358 367 10.1016/j.jchf.2014.03.009412714525023822 Search in Google Scholar

8 Agha AM, Parwani P, Guha A, et al. Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis. Open heart. 2018;5(2):e000881–e000881. AghaAM ParwaniP GuhaA Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis Open heart 2018 5 2 e000881 e000881 10.1136/openhrt-2018-000881617326730305910 Search in Google Scholar

9 Quarta CC, Kruger JL, Falk RH. Cardiac Amyloidosis. Circulation. 2012;126(12):178–182. QuartaCC KrugerJL FalkRH Cardiac Amyloidosis Circulation 2012 126 12 178 182 10.1161/CIRCULATIONAHA.111.06919522988049 Search in Google Scholar

10 Phelan D, Collier P, Thavendiranathan P, et al. Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart. 2012;98(19):1442 – 1448. PhelanD CollierP ThavendiranathanP Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis Heart 2012 98 19 1442 1448 10.1136/heartjnl-2012-30235322865865 Search in Google Scholar

11 Knight DS, Zumbo G, Barcella W, et al. Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles. JACC: Cardiovascular Imaging. 2019;12(5):823–833. KnightDS ZumboG BarcellaW Cardiac Structural and Functional Consequences of Amyloid Deposition by Cardiac Magnetic Resonance and Echocardiography and Their Prognostic Roles JACC: Cardiovascular Imaging 2019 12 5 823 833 10.1016/j.jcmg.2018.02.01629680336 Search in Google Scholar

12 Child N, Muhr T, Sammut E, et al. Prevalence of myocardial crypts in a large retrospective cohort study by cardiovascular magnetic resonance. Journal of Cardiovascular Magnetic Resonance. 2014;16(1):66. ChildN MuhrT SammutE Prevalence of myocardial crypts in a large retrospective cohort study by cardiovascular magnetic resonance Journal of Cardiovascular Magnetic Resonance 2014 16 1 66 10.1186/s12968-014-0066-0416478825231729 Search in Google Scholar

13 Bodez D, Ternacle J, Guellich A, et al. Prognostic value of right ventricular systolic function in cardiac amyloidosis. Amyloid. 2016; 23(3):158–167. BodezD TernacleJ GuellichA Prognostic value of right ventricular systolic function in cardiac amyloidosis Amyloid 2016 23 3 158 167 10.1080/13506129.2016.119426427348696 Search in Google Scholar

14 Dungu JN, Valencia O, Pinney JH, et al. CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis. JACC: Cardiovascular Imaging. 2014;7(2):133–142. DunguJN ValenciaO PinneyJH CMR-Based Differentiation of AL and ATTR Cardiac Amyloidosis JACC: Cardiovascular Imaging 2014 7 2 133 142 10.1016/j.jcmg.2013.08.01524412186 Search in Google Scholar

15 Wan K, Sun J, Han Y, et al. Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis. Circulation Journal. 2018;82(3):739–746. WanK SunJ HanY Increased Prognostic Value of Query Amyloid Late Enhancement Score in Light-Chain Cardiac Amyloidosis Circulation Journal 2018 82 3 739 746 10.1253/circj.CJ-17-046429093431 Search in Google Scholar

16 Siegismund, C.S., Escher, F., Lassner, D, et al. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis. Eur J Heart Fail, 2018: 751–757. SiegismundC.S. EscherF. LassnerD. Intramyocardial inflammation predicts adverse outcome in patients with cardiac AL amyloidosis Eur J Heart Fail 2018 751 757 10.1002/ejhf.103929067795 Search in Google Scholar